Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Oral Contraceptives Cut Ovarian Cancer Risk


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
AIDS and HIV Infection
Amenorrhea
Amniocentesis
More...

Related Healthscout Videos
 border=
A Welcome Message from Survivor PJ Hamel
Smother Says "Cut!"
Maryann and Paula
When's the Next Free Mammogram Day? October 17, 2008!!!
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Cialis
Detrol LA
Diflucan
More...

Related News Articles
 border=
Family History of Aneurysm Raises Stroke Risk for Smokers
Heart Drug May Be a Cancer Fighter
More 'Screen Time' Linked to Poor Fitness in Girls
Teen Birth Rate Up in 26 States in 2006
More...


Page:  << Prev | 1 | 2 | 3 | Next >>

"There is a slight transient risk of breast cancer and cervical cancer, but that goes away when you stop taking the Pill," she said. "But the decrease in ovarian cancer is persistent and long-lasting. The magnitude of this outweighs the other risk."

Beral doesn't think women should decide whether to take the Pill based on its ability to reduce ovarian cancer risk. "The decision to take the Pill is about contraception, but there is a bonus at the end of all that," she said.

Dr. Eduardo Franco, a professor of epidemiology and oncology at McGill University in Montreal, and co-author of an accompanying editorial in the journal, said this study answers a lot of lingering questions about the extent of the protection the Pill offers against ovarian cancer.

Text Continues Below



"Oral contraceptives are beneficial to women worldwide," Franco said. "In fact, a lot of ovarian cancers have been averted."

Franco noted that estrogen in oral contraceptives has a protective effect, yet after menopause hormone-replacement therapy is associated with an increased cancer risk. "What is protective before menopause gets to be harmful after menopause," he said. "It's an exercise in risk and benefit."

Another editorial in the same journal issue argues for making oral contraceptives available over-the-counter. "We believe that the case is now convincing. Women deserve the choice to obtain oral contraceptives over-the-counter, removing a huge and unnecessary barrier to a potentially powerful cancer-preventing agent," the journal editorial states.

"A strong message about the overall cancer-preventing benefits of oral contraceptives would be a positive public health message, empowering women to decide for themselves about the evidence," the editorial concludes.

However, Franco strongly disagrees with this proposal. "Because of the complexity of use and the potential for misuse, it should always be a prescription medication," he said.

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 1/25/2008

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Valerie Beral, M.D., Cancer Research UK Epidemiology Unit, Oxford University, Oxford, England; Eduardo Franco, M.D., professor, epidemiology and oncology, McGill University, Montreal, Quebec, Canada; Jan. 26, 2008, The Lancet


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service